Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2025-12-25 @ 2:52 AM
NCT ID:
NCT05912933
Eligibility Criteria:
Inclusion Criteria:
* Having prescription records of palbociclib from 15 December 2017 to 29 February 2024.
* Having any breast cancer records in same month as the first prescription date.
* Having laboratory tests and visit records (SS-MIX2) on or before 180 days prior to the first prescription date
* Having SS-MIX2 hospital-visit records within 180 days before the first prescription date
Exclusion Criteria:
* Having an absolute neutrophil count (ANC) less than the threshold value for grade 4 neutropenia within 30 days of the first prescription of palbociclib
* Having any records of anti-HER2 medication
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
0 Years
Study:
NCT05912933
Study Brief:
Protocol Section:
NCT05912933